Moreover, the regulation of DDR1 levels and centrosome clustering by E-cadherin is maintained in cancer cells, as demonstrated by the CRISPR-Cas9 knockout of E-cadherin in the human squamous carcinoma line A431 (Fig. S4, A–E). This evidence concerns the gene CDH1 and squamous cell carcinoma.